McLeod syndrome: a novel mutation, predominant psychiatric manifestations, and distinct striatal imaging findings
- PMID: 11261514
McLeod syndrome: a novel mutation, predominant psychiatric manifestations, and distinct striatal imaging findings
Abstract
The McLeod syndrome is an X-linked disorder caused by mutations of the XK gene encoding the XK protein. The syndrome is characterized by absent Kx erythrocyte antigen, weak expression of Kell blood group system antigens, and acanthocytosis. In some allelic variants, elevated creatine kinase, myopathy, neurogenic muscle atrophy, and progressive chorea are found. We describe a family with a novel point mutation in the XK gene consisting of a C to T base transition at nucleotide position 977, introducing a stop codon. Among seven affected males, five manifested with psychiatric disorders such as depression, bipolar disorder, or personality disorder, but only two presented with chorea Positron emission tomography and magnetic resonance volumetry revealed reduced striatal 2-fluoro-2-deoxy-glucose (FDG) uptake and diminished volumes of the caudate nucleus and putamen that correlated with disease duration. In contrast, none of 12 female mutation carriers showed psychiatric or movement disorders. However, a semidominant effect of the mutation was suggested by erythrocyte and blood group mosaicism and reduced striatal FDG uptake without structural abnormalities. Therefore, patients with psychiatric signs or symptoms segregating in an X-linked trait should be examined for acanthocytosis and Kell/Kx blood group serology.
Similar articles
-
McLeod phenotype associated with a XK missense mutation without hematologic, neuromuscular, or cerebral involvement.Transfusion. 2003 Jul;43(7):928-38. doi: 10.1046/j.1537-2995.2003.t01-1-00434.x. Transfusion. 2003. PMID: 12823753
-
A novel mutation of the McLeod syndrome gene in a Japanese family.J Neurol Sci. 2000 Jun 15;176(2):151-4. doi: 10.1016/s0022-510x(00)00307-5. J Neurol Sci. 2000. PMID: 10930599
-
McLeod syndrome resulting from a novel XK mutation.Br J Haematol. 2003 Aug;122(4):682-5. doi: 10.1046/j.1365-2141.2003.04474.x. Br J Haematol. 2003. PMID: 12899725
-
Kell, Kx and the McLeod syndrome.Baillieres Best Pract Res Clin Haematol. 1999 Dec;12(4):621-35. doi: 10.1053/beha.1999.0045. Baillieres Best Pract Res Clin Haematol. 1999. PMID: 10895256 Review.
-
XK-Associated McLeod Syndrome: Nonhematological Manifestations and Relation to VPS13A Disease.Transfus Med Hemother. 2022 Jan 25;49(1):4-12. doi: 10.1159/000521417. eCollection 2022 Feb. Transfus Med Hemother. 2022. PMID: 35221863 Free PMC article. Review.
Cited by
-
The neuropsychiatry of hyperkinetic movement disorders: insights from neuroimaging into the neural circuit bases of dysfunction.Tremor Other Hyperkinet Mov (N Y). 2013 Aug 26;3:tre-03-175-4242-1. doi: 10.7916/D8SN07PK. eCollection 2013. Tremor Other Hyperkinet Mov (N Y). 2013. PMID: 24032090 Free PMC article.
-
XKR4 Gene Effects on Cerebellar Development Are Not Specific to ADHD.Front Cell Neurosci. 2017 Dec 12;11:396. doi: 10.3389/fncel.2017.00396. eCollection 2017. Front Cell Neurosci. 2017. PMID: 29311829 Free PMC article.
-
Two McLeod patients with novel mutations in XK.J Neurol Sci. 2011 Jun 15;305(1-2):160-4. doi: 10.1016/j.jns.2011.02.028. Epub 2011 Apr 3. J Neurol Sci. 2011. PMID: 21463873 Free PMC article.
-
Spontaneously arising red cells with a McLeod-like phenotype in normal donors.Mutat Res. 2009 Dec 1;671(1-2):1-5. doi: 10.1016/j.mrfmmm.2009.03.009. Epub 2009 Apr 2. Mutat Res. 2009. PMID: 19909712 Free PMC article.
-
Clinical Features and Novel Pathogenic Variants of Chinese Patients With McLeod Syndrome and Chorea-Acanthocytosis.Mol Genet Genomic Med. 2024 Sep;12(9):e70015. doi: 10.1002/mgg3.70015. Mol Genet Genomic Med. 2024. PMID: 39324427 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
